Консенсус експертів: денервація нирок для лікування артеріальної гіпертензії

Atul Pathak, Xavier Girerd, Michel Azizi, Hakim Benamer, Jean-Michel Halimi, Pierre Lantelme, Thierry Lefevre, Mark Sapoval, від імені Французького товариства з артеріальної гіпертензії, Французького товариства кардіологів, робочої групи з атероми та інтервенційної кардіології Французького товариства радіологів

Література 

1. Bisognano J.D, Bakris G., Nadim M.K. et al. Baroreflex activa­tion therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial // J. Amer. Coll. Cardiol.– 2011.– Vol. 58.– P. 765–773.
2. Calhoun D.A., Jones D., Textor S. et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research // Circulation.– 2008.– Vol. 117.– P. e510–526.
3. Daugherty S.L., Powers J.D., Magid D.J. et al. Incidence and prognosis of resistant hypertension in hypertensive patients // Circulation.– 2012.– Vol. 125.– P. 1635–1642.
4. DiBona G.F. Neural control of the kidney: past, present, and future // Hypertension.– 2003.– Vol. 41.– P. 621–624.
5. DiBona G.F., Esler M. Translational medicine: the antihyper­ten­sive effect of renal denervation // Amer. J. Physiol. Regul. Integr. Comp. Physiol.– 2010.– Vol. 298.– P. R245–253.
6. Esler M.D., Krum H., Sobotka P.A. et al. Renal sympathetic dener­vation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial // Lancet.– 2010.– Vol. 376.– P. 1903–1909.
7. Evelyn K.A., Singh M.M., Chapman W.P. et al. Effect of thoracolum­bar sympathectomy on the clinical course of primary (essential) hypertension. A ten-year study of 100 sympathectomized patients compared with individually matched, symptomatically treated control subjects // Amer. J. Med.– 1960.– Vol. 28.– P. 188–221.
8. Godet-Mardirossian H., Girerd X., Vernay M. et al. Patterns of hypertension management in France (ENNS 2006-2007) // Eur. J. Prev. Cardiol.– 2012.– Vol. 19.– P. 213–220.
9. Hausberg M., Kosch M., Harmelink P. et al. Sympathetic nerve activity in end-stage renal disease // Circulation.– 2002.– Vol. 106.– P. 1974–1979.
10. Joyner M.J., Charkoudian N., Wallin B.G. Sympathetic nervous sys­tem and blood pressure in humans: individualized patterns of regulation and their implications // Hyperten­sion.– 2010.– Vol. 56.– P. 10–16.
11. Katholi R.E., Whitlow P.L., Winternitz S.R. et al. Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension // Hypertension.– 1982.– Vol. 4.– P. 166–174.
12. Krause T., Lovibond K., Caulfield M. et al. Management of hyper­tension: summary of NICE guidance // Brit. Med. J.– 2011.– Vol. 343.– P. d4891.
13. Krum H., Schlaich M., Sobotka P. et al. Novel procedure- and device-based strategies in the management of systemic hyper­tension // Eur. Heart J.– 2011.– Vol. 32.– P. 537–544.
14. Krum H., Schlaich M., Whitbourn R. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a mul­ticentre safety and proof-of-principle cohort study // Lancet.– 2009.– Vol. 373.– P. 1275–1281.
15. Morrissey D.M., Brookes V.S., Cooke W.T. Sympathectomy in the treatment of hypertension; review of 122 cases // Lancet.– 1953.– Vol. 1.– P. 403–408.
16. Persell S.D. Prevalence of resistant hypertension in the United States, 2003–2008 // Hypertension.– 2011.– Vol. 57.– P. 1076–1080.
17. Simplicity HTN-1 Investigators 2011. Catheter-based renal sym­pathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months // Hypertension. 2011.– Vol. 57.– P. 911–917.
18. Smithwick R.H., Thompson J.E. Splanchnicectomy for essen­tial hypertension; results in 1,266 cases // J. Amer. Med. Assoc.– 1953.– Vol. 152.– P. 1501–1504.